Tandem Diabetes Care, Inc.
TNDM
$21.58
-$0.01-0.05%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.74% | 2.17% | 8.46% | 22.30% | 43.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.74% | 2.17% | 8.46% | 22.30% | 43.62% |
| Cost of Revenue | -1.81% | -3.65% | 5.23% | 19.60% | 20.96% |
| Gross Profit | 6.35% | 7.73% | 11.58% | 25.07% | 68.77% |
| SG&A Expenses | 6.86% | 6.83% | 16.29% | 16.49% | 20.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.40% | -0.28% | 7.86% | 15.24% | 21.06% |
| Operating Income | 1,525.09% | 23.11% | -3.53% | 17.24% | 98.43% |
| Income Before Tax | 29,162.50% | -11.18% | -94.07% | -208.86% | 100.05% |
| Income Tax Expenses | 813.26% | -724.49% | -596.92% | 165.76% | 43.50% |
| Earnings from Continuing Operations | -178.01% | 8.97% | -70.05% | -205.64% | 102.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -178.01% | 8.97% | -70.05% | -205.64% | 102.52% |
| EBIT | 1,525.09% | 23.11% | -3.53% | 17.24% | 98.43% |
| EBITDA | 249.14% | 28.85% | -3.10% | 19.80% | 111.06% |
| EPS Basic | -176.32% | 11.81% | -64.84% | -200.67% | 102.48% |
| Normalized Basic EPS | 125.13% | 4.31% | -31.97% | 8.19% | 105.98% |
| EPS Diluted | -176.32% | 11.81% | -64.84% | -200.67% | 102.48% |
| Normalized Diluted EPS | 126.32% | 4.31% | -31.97% | 8.19% | 105.95% |
| Average Basic Shares Outstanding | 3.15% | 3.23% | 3.16% | 1.65% | 0.87% |
| Average Diluted Shares Outstanding | 2.81% | 3.23% | 3.16% | 1.65% | 1.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |